Universidade Estadual Paulista Júlio de Mesquita Filho Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2015
NCT03047278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Natalia Valadares de Moraes | Paulista School of Medicine-EPM, UNIFESP

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 4)

Neuralgia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 10